Oracle Investment Management’s Teladoc Health TDOC Stock Holding History

Oracle Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$4.55M	Buy	650,000 +179,500	+38%	+$1.41M	2.71%	4
2025 Q3	$3.64M	Sell	470,500 -279,600	-37%	-$2.18M	2.27%	9
2025 Q2	$6.53M	Buy	750,100 +605,800	+420%	+$4.39M	4.48%	5
2025 Q1	$1.15M	Sell	144,300 -153,400	-52%	-$1.55M	0.58%	15
2024 Q4	$2.71M	Buy	+297,700	New	+$2.87M	1.47%	12
2024 Q1	–	Sell	-639,600	Closed	-$13.8M	–	30
2023 Q4	$13.8M	Buy	+639,600	New	+$11.8M	8.38%	3

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Oracle Investment Management's TDOC Position: Q4 2025 in Review

Oracle Investment Management reduced its Teladoc Health (TDOC) stake by 50% in Q4 2025, selling an estimated $2.75M and leaving 354,338 shares worth $2.48M. The position accounts for 1.48% of the portfolio, ranked #11.

Oracle Investment Management first reported a position in TDOC in Q4 2023 and has held it in 5 quarters since. The position peaked at $5.45M in Q3 2025. 345 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

Oracle Investment Management held 354,338 shares of Teladoc Health worth $2.48M as of Q4 2025.
Oracle Investment Management sold 351,078 Teladoc Health shares in Q4 2025, an estimated $2.75M.
Teladoc Health made up 1.48% of Oracle Investment Management's portfolio in Q4 2025, its #11 holding.
Oracle Investment Management first reported a position in Teladoc Health in Q4 2023 and has held it in 5 quarters since.
Oracle Investment Management's Teladoc Health position peaked at $5.45M in Q3 2025.
345 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Oracle Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.